The Annual Peptide Therapeutics Symposium, 25 – 26 October 2018
This event held every year in San Diego, California, is a unique forum which brings together world leaders from academia, the biopharmaceutical industry, CMOs, CROs, and investors interested in all aspects of peptide R&D, including drug discovery, safety and toxicology, clinical development, manufacturing, pharmaceutical development, formulation, drug delivery, and regulatory affairs.
At this occasion, Stephen Daly, US General Manager at Adocia,will be presenting a Poster and making a presentation dedicated on « Adocia, BioChaperone®: A Platform to Improve Solubility and Stability of Therapeutic Proteins and Peptides ».
Date: Friday October 26th, 4:00 p.m. – 4:30 p.m.
Place: The Salk Institute – La Jolla, CA
To have a look on the program
Information about organizers:
The Peptide Therapeutics Foundation is a not-for-profit 501C(3), established in 2008 to promote research and development of peptide therapeutics. The Foundation and Symposium are supported by the following corporate sponsors: ChemPartner, Ferring Research Institute, Inc., Ipsen Bioscience, Inc., Novo Nordisk, the PolyPeptide Group, Zealand Pharma, and Zydus Cadila.